Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиAtara Biotherapeutics Мультипликаторы 2011-2024 | ATRA
Мультипликаторы по годам Atara Biotherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.3 | -2.3 | -4.3 | -4.7 | -2.4 | -6.9 | -10.1 | -4.6 | -8.1 | -4.3 | - | - | - |
P/S |
8.5 | 8.2 | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-2.6 | -2.2 | -3.6 | -4.2 | -5.7 | -5.3 | -4 | -2.8 | - | - | - | - | - |
EV (Enterprise Value) |
312 млн | 676 млн | 1.56 млрд | 1.38 млрд | 676 млн | 1.58 млрд | 1.16 млрд | 326 млн | 449 млн | 102 млн | 11.2 млн | 3.81 млн | - |
EBITDA per Share |
-2.56 | -2.69 | -3.53 | -4.07 | -5.63 | -5.33 | -4.04 | -2.81 | -2.28 | -5.65 | - | - | - |
EV/EBITDA |
-4.5 | -3.9 | -2.2 | -6.5 | -9.3 | -3.9 | -7.5 | -3.5 | - | - | - | ||
PEG |
0.02 | 0.42 | -0.54 | -0.31 | 0.32 | 0.22 | 0.22 | 0.2 | -0.13 | 0.01 | - | - | - |
P/B |
-0.7 | 4.1 | 5.3 | 3.1 | 2.4 | 4.7 | 6.8 | 1.4 | 1.5 | 1.2 | - | - | - |
P/CF |
-0.4 | -1.9 | -6.7 | -8.0 | -2.9 | -7.3 | -11.2 | -5.8 | -12.4 | -7.3 | - | - | - |
ROE % |
278.27 | -180.28 | -121.65 | -66.32 | -100.07 | -68.08 | -67.18 | -31.15 | -18.16 | -27.14 | - | - | - |
ROA % |
-166.84 | -60.65 | -72.66 | -52.14 | -84.85 | -58.88 | -54.87 | -29.95 | -17.61 | -26.39 | - | - | - |
ROCE % |
278.14 | -221.50 | -121.76 | -66.85 | -96.56 | -67.39 | -63.92 | -31.95 | -18.54 | -27.23 | - | - | - |
Current Ratio |
0.6 | 1.5 | 2.5 | 4.7 | 7.4 | 8.0 | 6.2 | 26.9 | 33.4 | 38.9 | - | - | - |
DSO |
1582.3 | 118.3 | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
1582.3 | 118.3 | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
1582.3 | 118.3 | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Atara Biotherapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.66 | -0.68 | -0.72 | - | -0.82 | 0.18 | -0.87 | - | -0.9 | -0.91 | -0.86 | - | -0.92 | -1.14 | -1.2 | - | -1.31 | -1.6 | -1.44 | - | -1.29 | -1.15 | -1.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.65 | -0.67 | -0.71 | - | -0.82 | -0.3 | -0.86 | - | -0.88 | -0.89 | -0.83 | - | -0.89 | -1.12 | -1.19 | - | -1.29 | -1.59 | -1.44 | - | -1.3 | -1.17 | -1.06 | - | -1.03 | -0.95 | -0.89 | - | -0.9 | -0.68 | -0.6 | - | -0.44 | -0.62 | -0.42 | - | - | -3.39 | -5.6 | - | -2.61 | - | - | -5.58 | - | - | - | - | - | - | - |
ROE % |
-976.71 | -1158.94 | -197.81 | -77.05 | -104.35 | -86.70 | -119.15 | -72.20 | -88.28 | -77.07 | -68.55 | -48.73 | -73.46 | -82.10 | -90.91 | -73.07 | -90.30 | -82.79 | -72.25 | -44.47 | -61.95 | -62.21 | -62.62 | -47.33 | -57.33 | -49.84 | -41.86 | -23.97 | -27.73 | -21.50 | -18.80 | -11.42 | -17.15 | -19.12 | -18.75 | -16.94 | 6.08 | 34.83 | 39.21 | 133.30 | 243.57 | 220.55 | 110.28 | 110.28 | - | - | - | - | - | - | - |
ROA % |
-113.41 | -99.27 | -66.18 | -40.77 | -59.59 | -55.58 | -78.16 | -51.95 | -64.59 | -58.42 | -53.24 | -38.31 | -59.27 | -67.60 | -76.10 | -61.96 | -76.85 | -70.78 | -62.09 | -38.46 | -52.74 | -52.12 | -51.73 | -38.65 | -48.27 | -43.60 | -38.16 | -23.04 | -26.70 | -20.73 | -18.18 | -11.07 | -16.65 | -18.57 | -18.22 | -16.47 | -21.36 | -20.68 | -16.43 | -4.89 | -4.89 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-45.23 | -90.45 | -102.93 | -97.03 | -124.38 | -106.50 | -119.36 | -72.29 | -88.45 | -77.26 | -68.79 | -49.17 | -74.13 | -82.92 | -92.04 | -74.28 | -91.40 | -83.57 | -72.55 | -44.15 | -60.80 | -60.33 | -60.05 | -45.09 | -55.29 | -48.85 | -41.83 | -24.58 | -28.47 | -22.15 | -19.28 | -11.63 | -17.40 | -19.28 | -18.88 | -17.02 | 6.15 | 35.08 | 39.47 | 132.98 | 242.80 | 219.64 | 109.82 | 109.82 | - | - | - | - | - | - | - |
Current Ratio |
0.8 | 1.0 | 1.3 | 1.5 | 2.0 | 2.4 | 2.3 | 2.5 | 3.2 | 3.6 | 4.1 | 4.7 | 4.7 | 4.7 | 4.7 | 6.6 | 6.6 | 6.6 | 6.6 | 7.4 | 7.4 | 7.4 | 7.4 | 5.5 | 5.5 | 5.5 | 5.5 | 25.9 | 25.9 | 25.9 | 25.9 | 32.9 | 32.9 | 32.9 | 32.9 | 36.1 | 36.1 | 36.1 | 36.1 | 29.6 | 29.6 | - | - | - | - | - | - | - | - | - | - |
DSO |
14.3 | 43.1 | 1511.6 | - | 9.1 | 1.1 | 10.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
14.3 | 43.1 | 1511.6 | - | 9.1 | 1.1 | 10.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
14.3 | 43.1 | 1511.6 | - | 9.1 | 1.1 | 10.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD